David P Meeker sold $5.1M of Rhythm Pharmaceuticals, Inc. (RYTM) stock

David P Meeker, President and CEO of Rhythm Pharmaceuticals, Inc. (RYTM), sold 50,000 shares of RYTM stock worth $5.1M, per an SEC Form 4 filed Sep 14, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Sep 14, 2026.

RYTM has moved -3.5% since the trade date, from $102.44 to $98.83 (Sep 21, 2026 close).